Target intelligence / Profile preview

Clostridioides difficile spore protein (C. difficile spore protein)

Target
C. difficile spore protein
Molecular classification
Receptor, Enzyme, Other
01

Overview

Clostridioides difficile spore proteins are a specialized set of proteins that constitute the protective layers and germination machinery of C. difficile spores (UniProt). These proteins, including the germination receptor CspC, the cortex-lytic enzyme SleC, and the exosporium protein BclA, are fundamental to the pathogen's life cycle and its ability to cause disease (Francis et al., 2013; Adams et al., 2013). CspC is particularly significant as it senses host bile acids to initiate the transition from a dormant spore to an active, toxin-producing vegetative cell (Nature, 2013). BclA and other surface proteins facilitate the adherence of spores to the intestinal mucosa, aiding in colonization and persistence (Phetcharaburanin et al., 2014). Since spores are the primary vehicle for transmission and are highly resistant to standard antibiotics, targeting these proteins is a promising strategy for developing anti-virulence therapies (PubMed). Such therapies aim to prevent the recurrence of C. difficile infection (CDI) by blocking germination or promoting immune-mediated clearance. Current research focuses on small molecule inhibitors of CspC and vaccine candidates targeting the exosporium to break the cycle of infection (Bhattacharjee et al., 2016). These targets are distinct from traditional antibiotics as they do not necessarily kill the bacteria but prevent their activation and colonization.

Other names
Clostridioides difficile spore proteinsC. diff spore proteinsSpore coat proteinsExosporium proteinsGermination-specific proteins
02

Mechanism of action

Inhibition of the CspC bile acid receptor to prevent spore germination; Inhibition of the SleC protease to block cortex degradation; Antibody-mediated neutralization of exosporium proteins like BclA to prevent host cell attachment (Francis et al., 2013; Adams et al., 2013; Phetcharaburanin et al., 2014).

03

Biological functions

Bacterial germinationAdhesionEnvironmental resistanceSpore assembly
04

Disease associations

Infection
05

Safety considerations

Potential for microbiome disruptionIncomplete eradication leading to persistenceEmergence of resistant strains with altered germination triggers
06

Interacting drugs

None approved

3 more in the full profile.

07

Biomarkers

C. difficile spore countFecal bile acid levelsGlutamate dehydrogenase (GDH)

Beyond the preview

Go deeper on Clostridioides difficile spore protein (C. difficile spore protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile spore protein (C. difficile spore protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call